-
effectivehealthcare-admin.ahrq.gov/products/c-difficile-update/research-protocol
December 01, 2019 - Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based … drug therapy.fs.
randomly.ab.
trial.ab.
groups.ab.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - Reduction in nosocomial transmission of
drug-resistant bacteria after introduction of
an alcohol-based … randomized controlled trial.pt.
5 controlled clinical trial.pt.
6 randomized.ab.
7 placebo.ab.
8 drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
April 08, 2024 - as similar to human milk
as possible and is established and strictly regulated by the Federal Food, Drug … J Food Drug Anal. 2021 Mar 15;29(1):1-14. doi: 10.38212/2224-
6614.3107. PMID: 35696228.
8.
-
effectivehealthcare-admin.ahrq.gov/news/2020-year-in-review
March 01, 2021 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
May 22, 2023 - participants for dietary/lifestyle
interventions while requiring biopsies, as
supposed to industry drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
September 02, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes
Source: www.effectivehealthcare.ahrq.gov
Published online: September 2, 2016
Evidence-based Practice Center Methodology Repor t Protocol
Project Title: Transparency of Repor ting Requirements
Repor t Topic: Tympanostomy Tubes
I. Background
Info…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/telehealth-covid-19-disposition-comments.pdf
January 03, 2023 - We do so by funding research and drug
development, advancing high-quality, specialized care, and partnering
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/case-management_research-protocol.pdf
June 06, 2011 - means to prevent adverse clinical events, such as falls, preventable
hospitalizations, or adverse drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - Research White Paper
Comparison of Effects as Evidence Evolves From
Single Trials to High-Quality Bodies of Evidence
Research White Paper
Comparison of Effects as Evidence Evolves From
Single Trials to High-Quality Bodies of Evidence
Prepared for:
Agency for Healthc…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
January 01, 2023 - N Mean Age (SD) Baseline CY-BOCS Score, Mean (SD) Intervention Type Pharmacolgical Interventions, Drug … Class (e.g., SSRI) Pharmacolgical Interventions, Drug Name Behavioral Intervention, Components (Choose
-
effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
December 01, 2019 - percutaneous coronary intervention
Dabigatran (Pradaxa®)
Boehringer Ingelheim GmbH
Investigational drug … Factor Xa Inhibitors
Rivaroxiban (Xarelto®)
Ortho-McNeil-Janssen
Investigational drug, not yet
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - percutaneous coronary intervention
Dabigatran
(Pradaxa®)
Boehringer
Ingelheim GmbH
Investigational drug … Factor Xa
Inhibitors
Rivaroxiban
(Xarelto®)
Ortho-McNeil-
Janssen
Investigational drug, not
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - percutaneous coronary intervention
Dabigatran
(Pradaxa®)
Boehringer
Ingelheim GmbH
Investigational drug … Factor Xa
Inhibitors
Rivaroxiban
(Xarelto®)
Ortho-McNeil-
Janssen
Investigational drug, not
-
effectivehealthcare-admin.ahrq.gov/products/cervical-degenerative-disease/protocol
July 01, 2022 - filter)
RCT hedge (sensitive)
((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug
-
effectivehealthcare-admin.ahrq.gov/products/worker-safety-wellness/protocol
December 01, 2024 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ocd-protocol.pdf
August 15, 2023 - magnetic resonance imaging
NRCS Nonrandomized comparative study
NSAID Nonsteroidal anti-inflammatory drug
-
effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014
August 01, 2019 - generated from the IT system, of what behavior is needed at a particular point in time, as well as (for drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
December 01, 2024 - Medicaid Services (CMS) to cover multicancer detection tests approved by the United States
Food and Drug … Food and Drug Administration.
Laboratory Developed Tests. 2024. … Department of Health and Human
Services Food and Drug
Administration. … Food and Drug Administration. … deoxyribonucleic acid
EHC Effective Health Care
EPC Evidence-based Practice Center
FDA Food and Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research-2013.pdf
January 01, 2013 - inflammatory arthritis, arthritis secondary to
systemic disease, and physical therapy treatment combined with drug … The former
refers to a drug or device being tested, while the latter is the data on patients randomized … to a
particular drug or device in a single study.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - As the
intervention is non-drug
randomization may not offer as
large a barrier as in a drug trial. … In some
diseases there is evidence that periods of drug free remission can be achieved. … Effective Health Care Program Selection
Criteria
Appropriateness
• Represents a health care drug,